Cure JM

Juvenile Myositis (JM or JDM for Juvenile Dermatomyositis) is a rare autoimmune disease that affects about 5,000 children in the United States and causes a variety of debilitating symptoms including muscle weakness and pain, severe fatigue, rashes, digestive difficulties, lung and heart problems, vasculitic ulcers, calcinosis and lipodystrophy.

Currently there is no cure, but some symptoms can be alleviated with the uses of off-label drugs, and some children experience a remission while others will battle JM for life. Complications from this disease and the medications used to control the symptoms can be serious and sometimes fatal. For more information about Juvenile Myositis, visit www.CureJM.org. #myositis #jdm #curejm @ Cure JM Foundation

Tags:

Author:

Myositis Support and Understanding Association (MSU) is a 501(c)(3) nonprofit organization with a mission to improve the day-to-day lives of Myositis patients. MSU is a patient-centered organization, founded by Myositis patients, for Myositis patients, and believes education, support, advocacy, and assistance are key to helping patients and caregivers. As a nonprofit, we rely on donations for funding and volunteers to help manage our fast growing organization.

View more information: Myositis Support

0 Comments

Leave a reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© Myositis Support and Understanding Association, Inc. 2010-2018. All Rights Reserved. MSU is a patient-centered 501(c)(3) nonprofit organization.

You agree to our Terms,Privacy Policy, and Cookie Policy by using and viewing our site.

Log in with your credentials

or    

Forgot your details?

Create Membership

Join our email updates and newsletter

Subscribe to our general myositis-related email updates. If you are a member of MSU, you will automatically recieve these updates and there is no need to subscribe here. To register for your free MSU membership and access to The Myositis Community Network, visit UnderstandingMyositis.org/register

You have been subscribed successfully!

Please look at your entries. There was an error.

Send this to a friend